Acebitor (Enalapril)

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acebitor (Enalapril)

What is Acebitor (Enalapril)?

Acebitor is a medicinal product containing the active substance enalapril. It belongs to a class of medications known as angiotensin-converting enzyme (ACE) inhibitors. This category of drugs is primarily utilized to manage conditions related to the cardiovascular system and blood pressure regulation.

Mechanism of Action

Enalapril functions by inhibiting the ACE enzyme, which is responsible for converting angiotensin I into angiotensin II. Angiotensin II is a potent natural substance in the body that causes blood vessels to narrow and tighten. By blocking the production of this substance, Acebitor facilitates the relaxation and widening of blood vessels. This process helps to lower blood pressure and reduces the workload on the heart, making it easier for the heart to pump blood throughout the body.

Therapeutic Use

As a cardiovascular medication, Acebitor is typically indicated for the following purposes:

  • Management of Hypertension: It is used to lower high blood pressure, which helps prevent long-term complications such as strokes or heart attacks.
  • Heart Failure Treatment: It is used to help manage symptomatic heart failure, often in combination with other medications, to improve heart function and reduce the need for hospitalization.
  • Prevention of Heart Failure: In certain patients who do not yet show symptoms but have a weakened heart (left ventricular dysfunction), it may be used to prevent the development of heart failure.

Acebitor is an oral medication that works systemically to support heart health and maintain stable vascular pressure.

Regulatory References

  1. NIH/NCBI Bookshelf: Enalapril
  2. WHO Essential Medicines List: Enalapril

What side effects are possible with Acebitor (Enalapril)?

Acebitor (Enalapril) safety information is officially classified according to the specific adverse reactions reported and their frequency of occurrence, as documented in governmental regulatory sources.

Frequency-Classified Adverse Reactions

The adverse effects are grouped by how often they appear in clinical use, based on regulatory standards:

  • Very Common (ge 1/10): Dizziness is listed as a very common occurrence in official labeling.
  • Common (ge 1/100 to < 1/10): Common reactions include Headache, Cough, Fatigue, and Hypotension (including orthostatic effects).
  • Rare (ge 1/10,000 to < 1/1,000): This category includes the serious adverse reaction Angioedema (swelling of the face, tongue, or throat), Hepatitis, and Pancreatitis.

These effects are formally categorized into System-Organ Classes, such as Nervous System Disorders, Cardiac and Vascular Disorders, and Respiratory Disorders.

Serious Adverse Reactions and Safety Notes

The regulatory safety profile highlights several serious adverse reactions, notably Angioedema, which is an infrequent but clinically significant swelling event. Other serious reactions documented include Agranulocytosis (a severe blood disorder) and severe cutaneous adverse reactions like Stevens-Johnson syndrome (SJS).

Specific time-related patterns are documented, indicating that adverse effects such as Hypotension and Dizziness are more likely to occur at the initiation of treatment and during dose escalation. Safety documentation also includes restrictions such as the contraindication of use in individuals with a history of Angioedema related to previous ACE inhibitor treatment, or during the second and third trimesters of pregnancy.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Enalapril (Acebitor) centers on the risk of profound cardiovascular and systemic effects, requiring mandated emergency intervention. The most prominent and expected clinical manifestation is Profound Hypotension (extremely low blood pressure), which may lead to dizziness, lightheadedness, and syncope (fainting). Other documented signs include changes in heart rate, such as tachycardia or bradycardia, and general symptoms like somnolence (sleepiness).

Severe overdose can result in life-threatening complications, including shock, acute kidney injury (Acute Renal Failure), and critical Hyperkalemia (high potassium levels). For any suspected overdose, regulatory guidance mandates that patients seek immediate medical attention and contact emergency services without delay.

Since no specific antidote is known, management is focused on symptomatic and supportive treatment. This often involves placing the patient in the supine position and administering intravenous fluid infusion to correct blood pressure. The active metabolite, Enalaprilat, can be removed through hemodialysis. Asymptomatic patients require close professional observation for a minimum of four to six hours, while symptomatic or hypotensive patients require at least 24 hours of hospital monitoring.

Therapeutic Uses of Acebitor (Enalapril)

Enalapril is a medication commonly used to help with conditions marked by increased physiological stress, relevant in areas where supportive symptom management is appropriate. Its uses are relevant across several domains, including the long-term management of hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction. This therapeutic domain is applied in conditions marked by increased physiological strain, focusing on addressing the physiological burden of high arterial pressure. The medication also plays a role in managing Diabetic Nephropathy.

In heart failure, the medication helps address symptom clusters related to systemic imbalance, such as shortness of breath and fatigue, which interfere with daily functioning. This use contributes to easing the overall symptom load and may assist with maintaining functional stability. Enalapril is generally used for the sustained, long-term support of these chronic conditions, contributing to the support of cardiovascular health over time. This may assist with maintaining a sense of stability when symptoms are more noticeable.


Therapeutic Focus: Quick Facts

  • Primary Use: Supports the long-term management of elevated systemic blood pressure (hypertension).
  • Symptom Relief: Helps address symptom clusters related to systemic imbalance and fatigue in symptomatic heart failure.
  • Supportive Role: Assists with maintaining functional stability in asymptomatic left ventricular dysfunction and Diabetic Nephropathy.

Eligibility and Restrictions for Use

Official Regulatory Eligibility Profile

Acebitor (Enalapril) is prohibited for use in several specific populations, as formally established by government regulatory bodies. Use is contraindicated (absolutely forbidden) for individuals with a history of angioedema related to a previous Angiotensin-Converting Enzyme (ACE) inhibitor, or those with hereditary or idiopathic angioedema. It is also contraindicated for mathbfpregnant women during the second and third trimesters due to the risk of fetal injury and death.

Furthermore, the medicine must not be used concomitantly with mathbfaliskiren in patients with diabetes or moderate-to-severe mathbfrenal impairment. It is also forbidden within 36 hours of taking a Neprilysin Inhibitor (e.g., Sacubitril/Valsartan).

Use is restricted or not recommended for other populations. It is not recommended for mathbfchildren younger than 1 month of age or in pediatric patients with severe kidney impairment (GFR < 30 mL/ min/1.73 m^2). Caution and close medical supervision are required for the mathbfelderly, patients with mathbfsevere volume or salt depletion, or those with mathbfpre-existing kidney or mathbfcollagen vascular diseases, often requiring an initial lower dose.

What should I know about interactions with other medicines?

The interaction profile for Acebitor (Enalapril) is defined by specific regulatory constraints, including several formal prohibitions and requirements for co-administration.

Contraindicated Combinations and Timing Rules

Co-administration with Sacubitril/Valsartan is prohibited; Enalapril must not be initiated until 36 hours after the last dose of that medication. Similarly, Enalapril is contraindicated with Aliskiren-containing products in patients who have diabetes mellitus or moderate-to-severe renal impairment (Glomerular Filtration Rate < 60 mL/min/1.73 m^2). These restrictions are documented due to the increased risks of hypotension, hyperkalemia, and renal function deterioration.

Pharmacodynamic and Exposure Effects

The medicine interacts with other agents that modify potassium and renal function. Use with Potassium-sparing diuretics or Potassium Supplements increases the risk of hyperkalemia (elevated serum potassium). Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may lead to deterioration of renal function, a risk particularly noted for elderly or volume-depleted patients. Enalapril is also documented to cause an increase in serum lithium levels when co-administered with lithium. Regarding administration, the absorption of Enalapril is officially documented as not influenced by the presence of food. The active metabolite, Enalaprilat, shows a prolonged half-life in patients with renal impairment, leading to potential accumulation.

Mechanism of Action

Acebitor (Enalapril) is converted to its active metabolite, Enalaprilat, which acts as a competitive inhibitor within the Renin-Angiotensin-Aldosterone System (RAAS), a key humoral pathway influencing vascular tone and fluid homeostasis. The drug's action is focused on binding to and inhibiting the Angiotensin-Converting Enzyme (ACE), thereby suppressing the formation of the vasoconstrictor, Angiotensin II. This molecular event initiates a cascade that leads to the modulation of vascular smooth muscle tone. Reducing Angiotensin II levels promotes the widening of blood vessels (vasodilation) and lowers the signaling for Aldosterone release. Reduced Aldosterone typically results in the promotion of sodium and water excretion in the renal tubules. This dual mechanistic outcome includes the reduction of systemic vascular resistance and the promotion of natriuresis (sodium and water excretion), leading to the modification of cardiac afterload and circulating blood volume.

Dosage and Administration Information

How Acebitor (Enalapril) is Used

Acebitor, containing Enalapril maleate, is administered via two official routes: oral tablets or solution (the prodrug) and intravenous (IV) injection of its active metabolite, Enalaprilat. Oral tablets may be taken with or without food, as the medicine's absorption is not influenced by meals. The usual dosing pattern for oral therapy involves once-daily administration for hypertension. For managing heart failure, the medication is often administered in two divided doses daily, with a gradual dose titration period.

Initial Dosing and Adjustment

Therapy typically begins with a low starting dose, such as 2.5 mg once or twice daily, which is gradually increased over several weeks under medical observation until the maintenance dose is reached. The maximum recommended daily oral dose is 40 mg.

Population-Specific Use

Dosing requires adjustment based on kidney function. For patients with severe renal impairment (Creatinine Clearance ≤ 30 mL/min), the initial oral dose must be reduced to 2.5 mg daily. For patients undergoing dialysis, the 2.5 mg dose should be administered after the procedure on dialysis days. In cases where oral administration is not possible, the active metabolite is given via slow IV infusion over at least a five-minute period, usually in a 1.25 mg dose every six hours.

Handling Missed Doses

If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. It is strictly instructed not to take a double dose to compensate for the missed one.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical research on enalapril, an angiotensin-converting enzyme (ACE) inhibitor, has focused on its use in hypertension (high blood pressure) and heart failure.

Mechanism of Action

Research has explored the drug's action, focusing on its role as a prodrug that converts to enalaprilat, which helps to inhibit a key enzyme in the body's natural blood pressure regulation system. This exploration focuses on potential effects related to certain biological pathways involved in cardiovascular function.


Key Clinical Trial Outcomes

Clinical trials have investigated enalapril's effects on major cardiovascular outcomes:

  • Heart Failure: Large-scale, randomized trials demonstrated that treatment was associated with a reduction in the risk of mortality and heart failure-related hospitalizations in patients with heart failure. This outcome was observed when enalapril was used alongside standard therapies such as diuretics.
  • High Blood Pressure: Studies have consistently evaluated enalapril's role in reducing both systolic and diastolic blood pressure in patients with chronic hypertension.

Safety and Tolerability Profile

The most common adverse events reported in clinical trials included cough, headache, and fatigue. The incidence of serious adverse events in the active treatment group was comparable to the placebo group across most studies. Studies have also noted the importance of blood pressure as an outcome measure when initiating treatment.

Frequently Asked Questions (FAQ)

Common questions about Acebitor (Enalapril) (FAQ)

Q: Does Acebitor work right away after I take it?

According to official product information, the effect of Acebitor begins to appear within one hour after you take the tablet. The blood pressure-lowering effect reaches its maximum, or peak effect, within about four to six hours after taking the dose.

Q: What is the difference between Acebitor and a beta-blocker?

Acebitor is classified as an ACE inhibitor, which means it regulates blood pressure by acting on the body's RAAS (Renin-Angiotensin-Aldosterone System). Beta-blockers are a separate class of medication. They work by blocking the effects of natural substances like adrenaline on the heart and blood vessels.

Q: Can Acebitor affect sleep or cause insomnia?

Official regulatory information lists common side effects like fatigue and headache. While insomnia (difficulty sleeping) is not listed as a frequent common reaction, persistent or severe changes to sleep are noted in safety documentation and may require review.

Q: Are there any food restrictions I need to follow while on Acebitor?

Official regulatory information advises caution or avoidance of products that contain high amounts of potassium, such as salt substitutes and potassium supplements. This is due to a risk of elevated potassium levels in the blood. The absorption of the drug itself is not affected by eating food.

Q: How does Acebitor affect heart remodeling in heart failure patients?

Clinical research indicates that Acebitor is associated with a reduction in major cardiovascular outcomes in heart failure. This is often explained in studies as relating to the drug's effect on reducing the degree of ventricular remodeling (changes to the size and shape of the heart’s chambers) that can occur in heart failure.

Q: Can Acebitor interact with natural or herbal supplements?

Official sources state there is limited formal information regarding interactions between Acebitor and most natural or herbal supplements. As regulatory bodies do not typically test these combinations, all supplements being taken should be reviewed for possible interactions.

Q: Does Acebitor interact with lithium or other psychiatric medications?

Regulatory documents indicate that Acebitor is known to interact with the medication lithium, potentially causing an increase in the levels of lithium in the blood. While this is the main interaction cited in this category, all interactions with psychiatric medications are addressed in the full interaction profile.

Q: Is Acebitor the same type of medicine as lisinopril or ramipril?

Acebitor (Enalapril) is in the same pharmacological class as lisinopril and ramipril, which are all Angiotensin-Converting Enzyme (ACE inhibitors). This means they act on the same key enzyme in the body to achieve their therapeutic effect. However, they are chemically distinct compounds with different trade names.

Q: What is the average time Acebitor takes to start working on blood pressure?

While the initial dose takes effect in hours, the time required to achieve the full, stable benefit on blood pressure is different for every patient. This typically involves a gradual dose adjustment process over several weeks until the optimal maintenance dose is reached.

Q: Is there a certain time of day that is better for taking Acebitor?

For high blood pressure, Acebitor is often prescribed as a once-daily medicine. Official patient information suggests that the first dose may be taken at bedtime to minimize the impact of possible initial dizziness.

Q: Can I still drink coffee or tea while taking Acebitor?

Official drug information does not prohibit the consumption of coffee or tea while taking Acebitor. However, the caffeine in these beverages is known to cause a brief, temporary increase in blood pressure for some individuals, which may affect monitoring.

Q: Is Acebitor considered a 'blood thinner'?

Acebitor is classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor, which is a class of medicine used to help manage high blood pressure and heart failure. It is not classified as a blood thinner (also known as an anticoagulant or antiplatelet medicine).

Q: What should I do if I feel dizzy after starting Acebitor?

Dizziness is a documented common side effect, especially when first starting treatment or increasing the dose. Official guidance describes that dizziness, particularly when initiating treatment, may be managed by lying down or sitting down until the feeling passes. Patients are noted to stand up slowly after these episodes.

Q: Can I take Acebitor if I have asthma or other breathing problems?

Official safety information states that you must inform the prescriber about any history of asthma or other pre-existing breathing problems. These conditions are considered precautionary and require a clinical review before use, but they are not listed as blanket contraindications for the medication.

Q: Does Acebitor have a severe interaction with alcohol?

According to official drug interaction profiles, consuming alcohol while taking Acebitor may cause an additive effect in lowering blood pressure. This can increase the likelihood of experiencing dizziness, light-headedness, or feeling faint.

Q: Can Acebitor raise my blood sugar levels?

Official regulatory information indicates that Acebitor may have an impact on blood sugar, sometimes causing it to lower blood glucose levels, particularly in patients who also have diabetes. The regulatory information indicates that closer blood sugar monitoring may be necessary for patients with diabetes when treatment is initiated.

Q: Is the long-term use of Acebitor safe for seniors?

Acebitor is commonly used for long-term treatment of chronic conditions in all adult populations. However, regulatory information notes that the elderly may require caution and often a lower starting dose due to potential changes in kidney function, which influences how the body processes the medication.

Q: Is Acebitor used to protect the kidneys in people with diabetes?

Official indications for Acebitor include the management of certain kidney problems. This can include diabetic kidney disease or nephropathy, as the drug can help to reduce the amount of protein that is passed out in the urine.

Q: Does the dry cough from Acebitor go away on its own?

The dry, persistent cough that is a common side effect associated with ACE inhibitors like Acebitor is noted to typically resolve after the medication is discontinued. Resolution may take anywhere from a few days up to a month following cessation of therapy.

Q: Why is it important to monitor blood pressure regularly while on Acebitor?

Regular blood pressure monitoring is necessary for two key reasons. It ensures that the medication is effectively helping to achieve the target blood pressure goals. It also allows for checking against the risk of hypotension (blood pressure dropping too low), which is most likely when starting treatment.

Q: What are the main research findings regarding Acebitor's use in children?

Regulatory information indicates that the drug is not recommended for use in children younger than one month old. For older children, studies have established appropriate dosing guidelines that allow the drug to be used, with the dosage often adjusted based on the child's weight.

Q: Is it necessary to avoid grapefruit when taking Acebitor?

Official regulatory information does not indicate a requirement to avoid grapefruit or grapefruit juice while taking Acebitor. Specific dietary advice, especially regarding fruit, is typically reserved for drugs in other pharmacological classes.

Q: What is the typical duration of treatment with Acebitor?

Treatment with Acebitor is commonly described in official patient information as a long-term therapy for chronic conditions, including high blood pressure and heart failure. The duration of therapy continues unless an adverse event requires discontinuation or the clinical status changes.

Q: Does Acebitor affect cholesterol levels?

Clinical studies that have examined the metabolic effects of Acebitor have generally shown that the medication does not cause statistically significant changes to key parameters like cholesterol and lipid levels in the blood.

Q: How is the long-term evidence for Acebitor described in medical studies?

Long-term clinical evidence, particularly in heart failure patients, has demonstrated significant outcomes. Studies have shown that the use of Enalapril is associated with a reduction in the risk of mortality and a decrease in hospitalizations related to heart failure.

Q: Can men taking Acebitor experience sexual side effects?

Official drug labeling notes that a potential side effect may include a decrease in sexual ability.

Q: What should I know about switching from a different blood pressure medicine to Acebitor?

Regulatory information specifies strict timing rules for switching from certain medications, particularly a class known as Neprilysin Inhibitors (e.g., Sacubitril/Valsartan). A mandatory 36-hour waiting period is required after the last dose of that medication before Acebitor can be started.

How should Acebitor (Enalapril) be stored and disposed of?

How to Store and Dispose of Acebitor (Enalapril)?

The storage and disposal of Acebitor (Enalapril) must follow official labeled instructions to maintain product integrity and safety.

Official Storage Requirements

Product Form Temperature Range Environmental Constraints
Oral Tablets Controlled room temperature (20 C to 25 C) Protect from moisture; keep container tightly closed.
Oral Liquid Refrigerated (2 C to 8 C) or Room Temperature (limited) Do not freeze; avoid excessive heat.

Stability and Handling

The Oral Liquid must be discarded after 60 days if stored at room temperature. The product must be preserved in its original, tightly closed container and should be kept out of the sight and reach of children in a secure location.

Disposal Instructions

Official disposal favors using a drug take-back program. If this is unavailable, unused or expired medication should be disposed of in household trash by mixing it with an unappealing substance and sealing it in a container. It is not listed for flushing. Avoid release to the environment or sewage systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acebitor (Enalapril) found in:

A-Z Index: